87 related articles for article (PubMed ID: 32122185)
1. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016.
Beckmann K; Garmo H; Nilsson P; Franck Lissbrant I; Widmark A; Stattin P
Acta Oncol; 2020 May; 59(5):549-557. PubMed ID: 32122185
[No Abstract] [Full Text] [Related]
2. High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Aibe N; Shimizu D; Kimoto T; Yamada K; Ueno A; Matsugasumi T; Yamada Y; Shiraishi T; Fujihara A; Okihara K; Yoshida K; Nakamura S
Sci Rep; 2021 Mar; 11(1):6165. PubMed ID: 33731856
[TBL] [Abstract][Full Text] [Related]
3. Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists.
Bonde TM; Garmo H; Stattin P; Nilsson P; Gunnlaugsson A; Swanberg D; Robinson D
Acta Oncol; 2023 Dec; 62(12):1815-1821. PubMed ID: 37850633
[TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United States.
Prasad RN; Gokun Y; Ritter AR; Jhawar SR; Vudatala S; Wang SJ; Martin D; Diaz DA
Brachytherapy; 2023; 22(1):53-57. PubMed ID: 36347762
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
Slevin F; Zattoni F; Checcucci E; Cumberbatch MGK; Nacchia A; Cornford P; Briers E; De Meerleer G; De Santis M; Eberli D; Gandaglia G; Gillessen S; Grivas N; Liew M; Linares Espinós EE; Oldenburg J; Oprea-Lager DE; Ploussard G; Rouvière O; Schoots IG; Smith EJ; Stranne J; Tilki D; Smith CT; Van Den Bergh RCN; Van Oort IM; Wiegel T; Yuan CY; Van den Broeck T; Henry AM
Eur Urol Oncol; 2023 Dec; ():. PubMed ID: 38151440
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Kadena S; Urabe F; Iwatani K; Suzuki H; Imai Y; Tashiro K; Tsuzuki S; Honda M; Koike Y; Shimomura T; Aoki M; Sato S; Takahashi H; Miki K; Kimura T
Int J Clin Oncol; 2023 Aug; 28(8):1092-1100. PubMed ID: 37227547
[TBL] [Abstract][Full Text] [Related]
7. A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate.
Fischer-Valuck BW; Gay HA; Patel S; Baumann BC; Michalski JM
Front Oncol; 2019; 9():1378. PubMed ID: 31921640
[TBL] [Abstract][Full Text] [Related]
8. The evolution of brachytherapy for prostate cancer.
Zaorsky NG; Davis BJ; Nguyen PL; Showalter TN; Hoskin PJ; Yoshioka Y; Morton GC; Horwitz EM
Nat Rev Urol; 2017 Jun; 14(7):415-439. PubMed ID: 28664931
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer.
Glaser SM; Kalash R; Bongiorni DR; Roberts MS; Balasubramani GK; Jacobs BL; Beriwal S; Heron DE; Greenberger JS
In Vivo; 2018; 32(1):113-120. PubMed ID: 29275307
[TBL] [Abstract][Full Text] [Related]
10. Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer.
Qureshy SA; Diven MA; Ma X; Marciscano AE; Hu JC; McClure TD; Barbieri C; Nagar H
JAMA Netw Open; 2023 Oct; 6(10):e2337165. PubMed ID: 37815829
[TBL] [Abstract][Full Text] [Related]
11. Secondary bladder and colorectal cancer after treatments for prostate cancer: A population based study.
Bárcena PGQ; Aprikian AG; Dragomir A
Cancer Med; 2024 Feb; 13(3):e6922. PubMed ID: 38351647
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Miyajima K; Suzuki H; Urabe F; Iwatani K; Imai Y; Yasue K; Yanagisawa T; Kimura S; Tashiro K; Tsuzuki S; Koike Y; Miki J; Yuen S; Sasaki T; Aoki M; Sato S; Takahashi H; Miki K; Kimura T
Int J Clin Oncol; 2023 Sep; 28(9):1200-1206. PubMed ID: 37432614
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparity in Prostate Cancer-Specific Mortality for High-Risk Prostate Cancer: A Population-Based Study.
Wang C; Kamrava M; King C; Steinberg ML
Cureus; 2017 Jan; 9(1):e961. PubMed ID: 28168138
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.
Ong WL; Nikitas J; Joseph D; Steigler A; Millar J; Valle L; Steinberg ML; Ma TM; Reiter RE; Rettig MB; Nickols NG; Chang A; Zaorsky NG; Spratt DE; Romero T; Kishan AU
Int J Radiat Oncol Biol Phys; 2023 Oct; ():. PubMed ID: 37802226
[TBL] [Abstract][Full Text] [Related]
15. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis.
Corrao G; Marvaso G; Mastroleo F; Biffi A; Pellegrini G; Minari S; Vincini MG; Zaffaroni M; Zerini D; Volpe S; Gaito S; Mazzola GC; Bergamaschi L; Cattani F; Petralia G; Musi G; Ceci F; De Cobelli O; Orecchia R; Alterio D; Jereczek-Fossa BA
Radiother Oncol; 2024 Jun; 195():110264. PubMed ID: 38561122
[TBL] [Abstract][Full Text] [Related]
16. National variation in the delivery of radiation oncology procedures in the non-facility-based setting.
Valle LF; Chu FI; Kundu P; Yoon SM; Gilchrist T; Steinberg ML; Raldow AC
Cancer Med; 2021 Jul; 10(14):4734-4742. PubMed ID: 34076341
[TBL] [Abstract][Full Text] [Related]
17. Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations.
Stanberry B; Webber-Jones N
Prostate Cancer Prostatic Dis; 2024 Mar; ():. PubMed ID: 38480973
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain.
Expósito J; Linares I; Castillo I; Martínez M; Vargas P; Herruzo I; Medina JA; Palacios A; Bayo E; Peracaula F; Jaén J; Sánchez JA; Ortiz MJ
Radiat Oncol; 2015 Dec; 10():265. PubMed ID: 26715201
[TBL] [Abstract][Full Text] [Related]
19. Incidence and survival of secondary malignancies after external beam radiotherapy for prostate cancer in the SEER database.
Huynh MJ; Eng L; Ngo LH; Power NE; Kamran SC; Pierce TT; Lo AC
Can Urol Assoc J; 2024 Apr; 18(4):121-128. PubMed ID: 38381941
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer.
Kissel M; Créhange G; Graff P
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
